Ramelmeier Rolf Andrew (0001789340)

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner SANGAMO THERAPEUTICS, INC 0001001233 2019-09-16 officer: EVP, Technical Operations

Items 1 - 18

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
D	2023-05-25		SANGAMO THERAPEUTICS, INC	4	F-InKind	--D	1750.0000	171467.0000	1	0001001233	Common Stock
D	2023-02-25		SANGAMO THERAPEUTICS, INC	4	F-InKind	--D	15618.0000	173217.0000	2	0001001233	Common Stock
A	2023-02-24		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	210000.0000	210000.0000	3	0001001233	Stock Option (Right to Buy)
A	2023-02-24		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	45000.0000	188835.0000	1	0001001233	Common Stock
A	2022-02-25		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	145800.0000	145800.0000	3	0001001233	Stock Option (Right to Buy)
A	2022-02-25		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	54000.0000	142429.0000	2	0001001233	Common Stock
D	2022-02-25		SANGAMO THERAPEUTICS, INC	4	F-InKind	--D	12388.0000	88429.0000	1	0001001233	Common Stock
A	2021-02-25		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	40000.0000	98199.0000	2	0001001233	Common Stock
A	2021-02-25		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	80000.0000	80000.0000	3	0001001233	Stock Option (Right to Buy)
D	2021-02-25		SANGAMO THERAPEUTICS, INC	4	F-InKind	--D	7779.0000	58199.0000	1	0001001233	Common Stock
D	2020-12-31		SANGAMO THERAPEUTICS, INC	4	S-Sale	--D	2464.0000	65978.0000	1	0001001233	Common Stock
D	2020-12-24	2020-12-24	SANGAMO THERAPEUTICS, INC	4	S-Sale	--D	3331.0000	68442.0000	1	0001001233	Common Stock
A	2020-02-25		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	110000.0000	110000.0000	3	0001001233	Stock Option (Right-to-Buy)
A	2020-02-25		SANGAMO THERAPEUTICS, INC	4	A-Award	--D	55000.0000	69128.0000	2	0001001233	Common Stock
D	2020-02-25		SANGAMO THERAPEUTICS, INC	4	F-InKind	--D	1703.0000	14128.0000	1	0001001233	Common Stock
-	-		SANGAMO THERAPEUTICS, INC	3	-	--D		15770.0000	1	0001001233	Common Stock
-	-		SANGAMO THERAPEUTICS, INC	3	-	--D			3	0001001233	Stock Option (Right to Buy)
-	-		SANGAMO THERAPEUTICS, INC	3	-	--D			2	0001001233	Stock Option (Right to Buy)

http://www.sec.gov/cgi-bin/own-disp

---